(function(){
			var content_array=["<p style=\"margin-left: 0in;\"><strong>About bioCSL Inc.<br \/> <\/strong>bioCSL Inc., located in King of Prussia, Pennsylvania, is the United States headquarters of bioCSL. Parent company, CSL Limited, has manufactured influenza vaccine in its Melbourne, Australia, facility since 1968. CSL Limited has made a $60 million (U.S.D.) investment in plant and equipment to double capacity at its Melbourne facility, making it one of the largest vaccine manufacturing facilities in the world. CSL-branded influenza vaccines are approved in 28 countries. At bioCSL Inc., delivering vaccines is our mission, protecting lives our passion. The CSL Group, which also includes CSL Research &amp; Development, CSL Plasma, and CSL Behring, has more than 11,000 employees globally and operates in 26 countries around the world.<\/p> \n<p style=\"margin-left: 0in;\">Media contact:<br \/> Sheila Burke <br \/> bioCSL <br \/> +1-610-290-7403<\/p>"];
			$("#dvExtra").html(content_array[0]);})();